Novartis phase III trial for next-generation malaria treatment KLU156 meets primary endpoint, with potential to combat antimalarial resistance: Basel Friday, November 14, 2025, 09 ...
A new phase 1 randomized controlled trial finds that a single dose of the ChAdox1 Rift Valley fever (RVF) vaccine appears ...
Former world No 1 talks to The National about her decision to retire, hopes of making the Hall of Fame, and growth of tennis ...
The National on MSN
President Sheikh Mohamed honours 'makers of hope' with Abu Dhabi Awards
Sheikh Mohamed personally handed the awards to the recipients during a ceremony marking the 20th anniversary of the ...
Cuba is fighting a wave of mosquito-borne illnesses including dengue and chikungunya virus that have swept the island in ...
ITV documentary details the repeated killing of unarmed civilians and the use of Palestinians as human shields ...
Did you get through your beach picnics unscathed this summer? Or did you return from a swim only to find a "seagull" (most ...
AZoLifeSciences on MSN
New Aquatic Arthropod Model Emerges from Visualization of Endosymbiosis in Ostracods
Ostracods, sometimes called seed shrimp, are nearly microscopic, aquatic organisms, inhabiting all types of marine and ...
ZME Science on MSN
Inside the Human Gene Editing Boom Driven by CRISPR Reshaping Everything From Medicine to Food
CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.
The handover followed the return of the remains of one of the last remaining Israeli hostages taken during the October 7 2023 attack.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback